Stavrou Spyridon, Crawford Daniel, Blouch Kristin, Browne Edward P, Kohli Rahul M, Ross Susan R
Department of Microbiology, Institute for Immunology and Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
PLoS Pathog. 2014 May 22;10(5):e1004145. doi: 10.1371/journal.ppat.1004145. eCollection 2014 May.
The apolipoprotein B editing complex 3 (A3) cytidine deaminases are among the most highly evolutionarily selected retroviral restriction factors, both in terms of gene copy number and sequence diversity. Primate genomes encode seven A3 genes, and while A3F and 3G are widely recognized as important in the restriction of HIV, the role of the other genes, particularly A3A, is not as clear. Indeed, since human cells can express multiple A3 genes, and because of the lack of an experimentally tractable model, it is difficult to dissect the individual contribution of each gene to virus restriction in vivo. To overcome this problem, we generated human A3A and A3G transgenic mice on a mouse A3 knockout background. Using these mice, we demonstrate that both A3A and A3G restrict infection by murine retroviruses but by different mechanisms: A3G was packaged into virions and caused extensive deamination of the retrovirus genomes while A3A was not packaged and instead restricted infection when expressed in target cells. Additionally, we show that a murine leukemia virus engineered to express HIV Vif overcame the A3G-mediated restriction, thereby creating a novel model for studying the interaction between these proteins. We have thus developed an in vivo system for understanding how human A3 proteins use different modes of restriction, as well as a means for testing therapies that disrupt HIV Vif-A3G interactions.
载脂蛋白B编辑复合体3(A3)胞苷脱氨酶是在基因拷贝数和序列多样性方面进化选择程度最高的逆转录病毒限制因子之一。灵长类动物基因组编码7个A3基因,虽然A3F和3G在限制HIV方面的重要性已得到广泛认可,但其他基因,特别是A3A的作用尚不清楚。实际上,由于人类细胞可以表达多个A3基因,且缺乏易于实验操作的模型,因此很难在体内剖析每个基因对病毒限制的单独贡献。为了克服这个问题,我们在小鼠A3基因敲除的背景下培育了人A3A和A3G转基因小鼠。利用这些小鼠,我们证明A3A和A3G都能限制鼠类逆转录病毒的感染,但作用机制不同:A3G被包装进病毒粒子并导致逆转录病毒基因组发生广泛脱氨基作用,而A3A未被包装,而是在靶细胞中表达时限制感染。此外,我们还表明,经过基因工程改造以表达HIV Vif的鼠白血病病毒克服了A3G介导的限制,从而创建了一个研究这些蛋白质之间相互作用的新模型。我们由此开发了一个体内系统,用于了解人类A3蛋白如何使用不同的限制模式,以及一种测试破坏HIV Vif - A3G相互作用疗法的方法。